BRCA2 and breast cancer: In the BC series, as expected, the eight carriers of pathogenic BRCA1 and BRCA2 variants were diagnosed earlier (median age 44 years, compared to 52 years in the whole series, though not statistically significant in a median test) and half of them had a first‐ or second‐degree family history of BC (compared to 13% in the whole series).